Nowadays, the VEGF family members and their receptors are considered important therapeutic targets [21, 22] and increased expression of these proteins in tumors has been associated with poor prognosis and increased risk of recurrence or metastasis in several types of cancers [23, 24]. The gene discussed is VEGFA; the disease is cancer.